Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells
- PMID: 30051958
- PMCID: PMC6220870
- DOI: 10.1002/cbic.201800209
Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells
Abstract
The aberrant misfolding and subsequent conversion of monomeric protein into amyloid aggregates characterises many neurodegenerative disorders, including Parkinson's and Alzheimer's diseases. These aggregates are highly heterogeneous in structure, generally of low abundance and typically smaller than the diffraction limit of light (≈250 nm). To overcome the challenges these characteristics pose to the study of endogenous aggregates formed in cells, we have developed a method to characterise them at the nanometre scale without the need for a conjugated fluorophore. Using a combination of DNA PAINT and an amyloid-specific aptamer, we demonstrate that this technique is able to detect and super-resolve a range of aggregated species, including those formed by α-synuclein and amyloid-β. Additionally, this method enables endogenous protein aggregates within cells to be characterised. We found that neuronal cells derived from patients with Parkinson's disease contain a larger number of protein aggregates than those from healthy controls.
Keywords: DNA PAINT; alpha-synuclein; amyloid formation; aptamers; induced pluripotent stem cells; neurodegenerative disorders.
© 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Conflict of interest statement
Figures
Similar articles
-
Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.Int J Mol Sci. 2018 Jan 24;19(2):336. doi: 10.3390/ijms19020336. Int J Mol Sci. 2018. PMID: 29364151 Free PMC article. Review.
-
Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates.FEBS J. 2018 Oct;285(19):3604-3630. doi: 10.1111/febs.14409. Epub 2018 Mar 4. FEBS J. 2018. PMID: 29453901 Review.
-
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.Molecules. 2020 Jan 29;25(3):580. doi: 10.3390/molecules25030580. Molecules. 2020. PMID: 32013170 Free PMC article.
-
Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.J Neuroinflammation. 2021 Jun 3;18(1):124. doi: 10.1186/s12974-021-02158-3. J Neuroinflammation. 2021. PMID: 34082772 Free PMC article.
-
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease.Brain. 2022 Apr 18;145(2):632-643. doi: 10.1093/brain/awab306. Brain. 2022. PMID: 34410317 Free PMC article.
Cited by
-
Cerebral organoids with chromosome 21 trisomy secrete Alzheimer's disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy.Mol Psychiatry. 2023 Dec 15. doi: 10.1038/s41380-023-02333-3. Online ahead of print. Mol Psychiatry. 2023. PMID: 38102482
-
Two-color coincidence single-molecule pulldown for the specific detection of disease-associated protein aggregates.Sci Adv. 2023 Nov 17;9(46):eadi7359. doi: 10.1126/sciadv.adi7359. Epub 2023 Nov 15. Sci Adv. 2023. PMID: 37967183 Free PMC article.
-
Imaging Protein Aggregates in Parkinson's Disease Serum Using Aptamer-Assisted Single-Molecule Pull-Down.Anal Chem. 2023 Oct 17;95(41):15254-15263. doi: 10.1021/acs.analchem.3c02515. Epub 2023 Oct 2. Anal Chem. 2023. PMID: 37782556 Free PMC article.
-
Synaptic expression of TAR-DNA-binding protein 43 in the mouse spinal cord determined using super-resolution microscopy.Front Mol Neurosci. 2023 Aug 21;16:1027898. doi: 10.3389/fnmol.2023.1027898. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37671010 Free PMC article.
-
Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell models.Nat Mach Intell. 2023;5(8):933-946. doi: 10.1038/s42256-023-00702-9. Epub 2023 Aug 10. Nat Mach Intell. 2023. PMID: 37615030 Free PMC article.
References
-
- Chiti F., Dobson C. M., Annu. Rev. Biochem. 2006, 75, 333–366. - PubMed
-
- Barghorn S., Davies P., Mandelkow E., Biochemistry 2004, 43, 1694–1703. - PubMed
-
- Spillantini M. G., Schmidt M. L., Lee V. M.-Y., Trojanowski J. Q., Jakes R., Goedert M., Nature 1997, 388, 839–840. - PubMed
-
- Barrett P. J., Greenamyre J. T., Brain Res. 2015, 1628, 247–253. - PubMed
-
- Vicente Miranda H., Szego É. M., Oliveira L. M. A., Breda C., Darendelioglu E., de Oliveira R. M., Ferreira D. G., Gomes M. A., Rott R., Oliveira M., et al., Brain 2017, 140, 1399–1419. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
